Genesco Inc. filed a current report on September 3, 2026, disclosing second fiscal quarter results for the period ended August 1, 2026, via a press release and slide presentation furnished as exhibits.
Equity Bancshares, Inc. filed an 8-K with the SEC on September 3, 2026, disclosing that on September 2, 2026, it entered into an Agreement and Plan of Reorganization to acquire Lincoln Bancorp, an Iowa corporation and parent of Lincoln Savings Bank, in a transaction …
Liquidia Corporation filed a current report on September 3, 2026, disclosing that the U.S. Food and Drug Administration has granted Fast Track Designation to YUTREPIA (treprostinil) inhalation powder for the treatment of Raynaud's phenomenon associated with systemic sclerosis.
Hillman Solutions Corp. filed a Form 8-K on September 3, 2026, disclosing the August 28, 2026 completion of its acquisition of Kanebridge, LLC for an aggregate purchase price of approximately $315 million, along with a related $200.0 million term loan amendment.
Climb Bio, Inc. filed a Form 8-K with the SEC on September 3, 2026, disclosing positive results from its ongoing Phase 1 trial of CLYM116 and providing a strategy update for development in IgA nephropathy.
LB Pharmaceuticals Inc filed a Form 8-K on September 3, 2026, disclosing the appointment of Joseph M. Miller as Chief Financial Officer, effective September 2, 2026.
NVIDIA Corporation filed a Form 8-K on September 3, 2026, disclosing that it entered into a definitive agreement on September 2, 2026, to acquire Hugging Face, Inc., an open-source AI platform and community operator.
AbbVie Inc. filed a Form 8-K with the SEC on September 3, 2026, disclosing under Item 7.01 (Regulation FD) the completion of its acquisition of Apogee Therapeutics, Inc., as announced in an attached press release dated the same day.
Apogee Therapeutics, Inc. filed a Form 8-K on September 3, 2026, reporting the completion of its merger with a wholly owned subsidiary of AbbVie Inc., making Apogee an indirect wholly owned subsidiary of AbbVie at a total equity value of approximately $10.9 billion.
CarGurus, Inc. filed an 8-K with the SEC on September 3, 2026, disclosing the appointment of Matthew Mandel as Chief Financial Officer, principal financial officer, and principal accounting officer, effective October 19, 2026.